CCA to lift profile of TB treatment

NEW YORK: The Global Alliance for TB Drug Development has called in Chandler Chicco Agency (CCA) as it seeks to develop the first new tuberculosis treatment regimen in more than three decades.

The non-profit drug developer has hired CCA as drug candidates progress through clinical trials. The agency is briefed to raise awareness of the alliance and help boost its funding, said Gwynne Oosterbaan, assistant director of public affairs and advocacy at the New York-based body.

Oosterbaan said: 'Most people in the West don't see TB as a major problem - you're starting with a high hurdle. The first issue is getting us out there and getting us known.'

Sydney Rubin, who heads CCA's Washington office, which will oversee the business, said: 'The world can't wait any longer for a TB cure.' Thousands of patients are needed to test the regimen.

The alliance's partners include drugs giants GlaxoSmithKline and Bayer Pharmaceuticals, plus the World Health Organisation, the Bill and Melinda Gates Foundation and the United States Agency for International Development.

TB is estimated to affect a third of the world's total population.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in